Updated Jul 16, 2026
BERNS PAUL L has filed 2 SEC Form 4 filings across 1 company in the last 90 days — active on both sides. Lifetime open-market purchases: $20.00M. Lifetime open-market sales: $34K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-24 | KARD | Kardigan, Inc. | P — Open-market purchase | 1.25M | $16.00 | $20.00M |
| 2026-06-22 | KARD | Kardigan, Inc. | A — Grant or award | 20.7K | $0.00 | |
| 2026-06-22 | KARD | Kardigan, Inc. | J — Other acquisition / disposition | 13.79M | — | |
| 2026-02-19 | NMRA | Neumora Therapeutics, Inc. | S — Open-market sale | 9.8K | $3.51 | $34K |
| 2025-11-14 | MTSR | Metsera, Inc. | D — Derivative transaction | 957.6K | — | |
| 2025-11-14 | MTSR | Metsera, Inc. | D — Derivative transaction | 8.31M | — | |
| 2025-11-14 | MTSR | Metsera, Inc. | D — Derivative transaction | 7.52M | — | |
| 2025-11-14 | MTSR | Metsera, Inc. | D — Derivative transaction | 4.0K | — | |
| 2024-12-27 | NMRA | Neumora Therapeutics, Inc. | G — Bona-fide gift | 133.1K | $0.00 | |
| 2024-12-27 | NMRA | Neumora Therapeutics, Inc. | G — Bona-fide gift | 133.1K | $0.00 | |
| 2024-12-27 | NMRA | Neumora Therapeutics, Inc. | G — Bona-fide gift | 133.1K | $0.00 |
BERNS PAUL L is a corporate insider — currently tracked as Director, 10% Owner of Kardigan, Inc. (KARD). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($20.00M) and 1 open-market sales ($34K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live BERNS PAUL L profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.